Member Publications

Cancer Related High Impact >10 Publications
(Jan 1, 2018- June 1, 2018)

*Cancer Center members in bold

  1. Alexander B, Brown P, Ahluwalia M, Aoyama H, Baumert B, Chang S, Gaspar L, Kalkanis S, Macdonald D, Mehta M, Soffietti R, Suh J, van den Bent M, Vogelbaum M, Wefel J, Lee E, Wen P. (2018) Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group. Lancet Oncol. 1:e33-e42.
  2. Almassi N, Reichard C, Li J, Russell C, Perry J, Ryan C, Friedlander T, Sharifi N. (2018) HSD3B1 and Response to a Nonsteroidal CYP17A1 Inhibitor in Castration-Resistant Prostate Cancer. JAMA Oncol 4:554-557. PMC ID: PMC5933361
  3. Bailey S, Zhang X, Desai K, Aid M, Corradin O, Cowper-Sal Lari R, Akhtar-Zaidi B, Scacheri P, Haibe-Kains B, Lupien M. (2018) Publisher Correction: ZNF143 provides sequence specificity to secure chromatin interactions at gene promoters. Nat Commun :16194. PMC ID: PMC5898460
  4. Balasubramanian S, Aly M, Nagata Y, Bat T, Przychodzen B, Hirsch C, Adema V, Visconte V, Kuzmanovic T, Radivoyevitch T, Nazha A, Mukherjee S, Sekeres M, Maciejewski J. (2018) Distinct clinical and biological implications of various DNMT3A mutations in myeloid neoplasms. Leukemia 2:550-553.
  5. Basak S, Gicheru Y, Samanta A, Molugu S, Huang W, Fuente M, Hughes T, Taylor D, Nieman M, Moiseenkova-Bell V, Chakrapani S. (2018) Cryo-EM structure of 5-HT Nat Commun 1:514. PMC ID: PMC5802770
  6. Bhagya Rao B, Kalady M, Burke C. (2018) Intraoperative enteroscopy in Peutz-Jeghers syndrome. Am. J. Gastroenterol. 
  7. Camidge D, Lee E, Lin N, Margolin K, Ahluwalia M, Bendszus M, Chang S, Dancey J, de Vries E, Harris G, Hodi F, Lassman A, Macdonald D, Peereboom D, Schiff D, Soffietti R, van den Bent M, Wefel J, Wen P. (2018) Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group. Lancet Oncol. 1:e20-e32.
  8. Chaturvedi S, Arnold D, McCrae K. (2018) Splenectomy for immune thrombocytopenia: down but not out. Blood 11:1172-1182. PMC ID: PMC5855018
  9. Choueiri T, Larkin J, Oya M, Thistlethwaite F, Martignoni M, Nathan P, Powles T, McDermott D, Robbins P, Chism D, Cho D, Atkins M, Gordon M, Gupta S, Uemura H, Tomita Y, Compagnoni A, Fowst C, di Pietro A, Rini B. (2018) Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose-finding and dose-expansion, phase 1b trial. Lancet Oncol. 4:451-460.
  10. Codipilly D, Chandar A, Singh S, Wani S, Shaheen N, Inadomi J, Chak A, Iyer P. (2018) The Effect of Endoscopic Surveillance in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis. Gastroenterology 8:2068-2086.e5. PMC ID: PMC5985204
  11. Courtney K, Infante J, Lam E, Figlin R, Rini B, Brugarolas J, Zojwalla N, Lowe A, Wang K, Wallace E, Josey J, Choueiri T. (2018) Phase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2a Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma. J. Clin. Oncol. 9:867-874.
  12. Dai Y, Zhang A, Shan S, Gong Z, Zhou Z. (2018) Structural basis for recognition of 53BP1 tandem Tudor domain by TIRR. Nat Commun 1:2123. PMC ID: PMC5974088
  13. DiNardo C, Stein E, de Botton S, Roboz G, Altman J, Mims A, Swords R, Collins R, Mannis G, Pollyea D, Donnellan W, Fathi A, Pigneux A, Erba H, Prince G, Stein A, Uy G, Foran J, Traer E, Stuart R, Arellano M, Slack J, Sekeres M, Willekens C, Choe S, Wang H, Zhang V, Yen K, Kapsalis S, Yang H, Dai D, Fan B, Goldwasser M, Liu H, Agresta S, Wu B, Attar E, Tallman M, Stone R, Kantarjian H. (2018) Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML. N. Engl. J. Med. :.
  14. Drilon A, Laetsch T, Kummar S, DuBois S, Lassen U, Demetri G, Nathenson M, Doebele R, Farago A, Pappo A, Turpin B, Dowlati A, Brose M, Mascarenhas L, Federman N, Berlin J, El-Deiry W, Baik C, Deeken J, Boni V, Nagasubramanian R, Taylor M, Rudzinski E, Meric-Bernstam F, Sohal D, Ma P, Raez L, Hechtman J, Benayed R, Ladanyi M, Tuch B, Ebata K, Cruickshank S, Ku N, Cox M, Hawkins D, Hong D, Hyman D. (2018) Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children. N. Engl. J. Med. 8:731-739. PMC ID: PMC5857389
  15. Dziedzic S, Su Z, Jean Barrett V, Najafov A, Mookhtiar A, Amin P, Pan H, Sun L, Zhu H, Ma A, Abbott D, Yuan J. (2018) ABIN-1 regulates RIPK1 activation by linking Met1 ubiquitylation with Lys63 deubiquitylation in TNF-RSC. Nat. Cell Biol. 1:58-68. PMC ID: PMC5741489
  16. Forastiere A, Ismaila N, Lewin J, Nathan C, Adelstein D, Eisbruch A, Fass G, Fisher S, Laurie S, Le Q, O'Malley B, Mendenhall W, Patel S, Pfister D, Provenzano A, Weber R, Weinstein G, Wolf G. (2018) Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. J. Clin. Oncol. 11:1143-1169.
  17. Geyer F, Li A, Papanastasiou A, Smith A, Selenica P, Burke K, Edelweiss M, Wen H, Piscuoglio S, Schultheis A, Martelotto L, Pareja F, Kumar R, Brandes A, Fan D, Basili T, Da Cruz Paula A, Lozada J, Blecua P, Muenst S, Jungbluth A, Foschini M, Wen H, Brogi E, Palazzo J, Rubin B, Ng C, Norton L, Varga Z, Ellis I, Rakha E, Chandarlapaty S, Weigelt B, Reis-Filho J. (2018) Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas. Nat Commun 1:1816. PMC ID: PMC5940840
  18. Giri V, Knudsen K, Kelly W, Abida W, Andriole G, Bangma C, Bekelman J, Benson M, Blanco A, Burnett A, Catalona W, Cooney K, Cooperberg M, Crawford D, Den R, Dicker A, Eggener S, Fleshner N, Freedman M, Hamdy F, Hoffman-Censits J, Hurwitz M, Hyatt C, Isaacs W, Kane C, Kantoff P, Karnes R, Karsh L, Klein E, Lin D, Loughlin K, Lu-Yao G, Malkowicz S, Mann M, Mark J, McCue P, Miner M, Morgan T, Moul J, Myers R. (2018) Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017. J. Clin. Oncol. 4:414-424.
  19. Gravis G, Boher J, Chen Y, Liu G, Fizazi K, Carducci M, Oudard S, Joly F, Jarrard D, Soulie M, Eisenberger M, Habibian M, Dreicer R, Garcia J, Hussain M, Kohli M, Vogelzang N, Picus J, DiPaola R, Sweeney C. (2018) Burden of Metastatic Castrate Naive Prostate Cancer Patients, to Identify Men More Likely to Benefit from Early Docetaxel: Further Analyses of CHAARTED and GETUG-AFU15 Studies. Eur. Urol. 6:847-855.
  20. Harshman L, Chen Y, Liu G, Carducci M, Jarrard D, Dreicer R, Hahn N, Garcia J, Hussain M, Shevrin D, Eisenberger M, Kohli M, Plimack E, Cooney M, Vogelzang N, Picus J, Dipaola R, Sweeney C. (2018) Seven-Month Prostate-Specific Antigen Is Prognostic in Metastatic Hormone-Sensitive Prostate Cancer Treated With Androgen Deprivation With or Without Docetaxel. J. Clin. Oncol. 4:376-382. PMC ID: PMC5805480
  21. Hayashi H, Hess D, Zhang R, Sugi K, Gao H, Tan B, Bowles D, Milano C, Jain M, Koch W, Stamler J. (2018) S-Nitrosylation of ß-Arrestins Biases Receptor Signaling and Confers Ligand Independence. Mol. Cell 3:473-487.e6. PMC ID: PMC5940012
  22. Hearn J, Xie W, Nakabayashi M, Almassi N, Reichard C, Pomerantz M, Kantoff P, Sharifi N. (2018) Association of HSD3B1 Genotype With Response to Androgen-Deprivation Therapy for Biochemical Recurrence After Radiotherapy for Localized Prostate Cancer. JAMA Oncol 4:558-562. PMC ID: PMC5933377
  23. Herjan T, Hong L, Bubenik J, Bulek K, Qian W, Liu C, Li X, Chen X, Yang H, Ouyang S, Zhou H, Zhao J, Vasu K, Cockman E, Aronica M, Asosingh K, Licatalosi D, Qin J, Fox P, Hamilton T, Driscoll D, Li X. (2018) IL-17-receptor-associated adaptor Act1 directly stabilizes mRNAs to mediate IL-17 inflammatory signaling. Nat. Immunol. 4:354-365.
  24. Hu Y, Lin J, Fang H, Fang J, Li C, Chen W, Liu S, Ondrejka S, Gong Z, Reu F, Maciejewski J, Yi Q, Zhao J. (2018) Targeting the MALAT1/PARP1/LIG3 complex induces DNA damage and apoptosis in multiple myeloma. Leukemia :.
  25. Hwang W, Tendulkar R, Niemierko A, Agrawal S, Stephans K, Spratt D, Hearn J, Koontz B, Lee W, Michalski J, Pisansky T, Liauw S, Abramowitz M, Pollack A, Moghanaki D, Anscher M, Den R, Zietman A, Stephenson A, Efstathiou J. (2018) Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features. JAMA Oncol :e175230. PMC ID: PMC5885162
  26. Jeon J, Du M, Schoen R, Hoffmeister M, Newcomb P, Berndt S, Caan B, Campbell P, Chan A, Chang-Claude J, Giles G, Gong J, Harrison T, Huyghe J, Jacobs E, Li L, Lin Y, Le Marchand L, Potter J, Qu F, Bien S, Zubair N, Macinnis R, Buchanan D, Hopper J, Cao Y, Nishihara R, Rennert G, Slattery M, Thomas D, Woods M, Prentice R, Gruber S, Zheng Y, Brenner H, Hayes R, White E, Peters U, Hsu L. (2018) Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors. Gastroenterology 8:2152-2164.e19. PMC ID: PMC5985207
  27. Jonasch E, Slack R, Geynisman D, Hasanov E, Milowsky M, Rathmell W, Stovall S, Juarez D, Gilchrist T, Pruitt L, Ornstein M, Plimack E, Tannir N, Rini B. (2018) Phase II Study of Two Weeks on, One Week off Sunitinib Scheduling in Patients With Metastatic Renal Cell Carcinoma. J. Clin. Oncol. 16:1588-1593.
  28. Karnes R, Choeurng V, Ross A, Schaeffer E, Klein E, Freedland S, Erho N, Yousefi K, Takhar M, Davicioni E, Cooperberg M, Trock B. (2018) Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features. Eur. Urol. 2:168-175. PMC ID: PMC5632569
  29. Kishan A, Cook R, Ciezki J, Ross A, Pomerantz M, Nguyen P, Shaikh T, Tran P, Sandler K, Stock R, Merrick G, Demanes D, Spratt D, Abu-Isa E, Wedde T, Lilleby W, Krauss D, Shaw G, Alam R, Reddy C, Stephenson A, Klein E, Song D, Tosoian J, Hegde J, Yoo S, Fiano R, D'Amico A, Nickols N, Aronson W, Sadeghi A, Greco S, Deville C, McNutt T, DeWeese T, Reiter R, Said J, Steinberg M, Horwitz E, Kupelian P. (2018) Radical Prostatectomy, External Beam Radiotherapy, or External Beam Radiotherapy With Brachytherapy Boost and Disease Progression and Mortality in Patients With Gleason Score 9-10 Prostate Cancer. JAMA 9:896-905. PMC ID: PMC5885899
  30. Klein A, Wolpin B, Risch H, Stolzenberg-Solomon R, Mocci E, Zhang M, Canzian F, Childs E, Hoskins J, Jermusyk A, Zhong J, Chen F, Albanes D, Andreotti G, Arslan A, Babic A, Bamlet W, Beane-Freeman L, Berndt S, Blackford A, Borges M, Borgida A, Bracci P, Brais L, Brennan P, Brenner H, Bueno-de-Mesquita B, Buring J, Campa D, Capurso G, Cavestro G, Chaffee K, Chung C, Cleary S, Cotterchio M, Dijk F, Duell E, Foretova L, Fuchs C, Funel N...Klein E... (2018) Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Nat Commun 1:556. PMC ID: PMC5805680
  31. Kyriakopoulos C, Chen Y, Carducci M, Liu G, Jarrard D, Hahn N, Shevrin D, Dreicer R, Hussain M, Eisenberger M, Kohli M, Plimack E, Vogelzang N, Picus J, Cooney M, Garcia J, DiPaola R, Sweeney C. (2018) Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial. J. Clin. Oncol. 11:1080-1087. PMC ID: PMC5891129
  32. LaCasce A, Bociek R, Sawas A, Caimi P, Agura E, Matous J, Ansell S, Crosswell H, Islas-Ohlmayer M, Behler C, Cheung E, Forero-Torres A, Vose J, O'Connor O, Josephson N, Wang Y, Advani R. (2018) Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma. Blood :.
  33. Lambertini M, Moore H, Leonard R, Loibl S, Munster P, Bruzzone M, Boni L, Unger J, Anderson R, Mehta K, Minton S, Poggio F, Albain K, Adamson D, Gerber B, Cripps A, Bertelli G, Seiler S, Ceppi M, Partridge A, Del Mastro L. (2018) Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level Data. J. Clin. Oncol. :JCO2018780858.
  34. Liu Y, Sethi N, Hinoue T, Schneider B, Cherniack A, Sanchez-Vega F, Seoane J, Farshidfar F, Bowlby R, Islam M, Kim J, Chatila W, Akbani R, Kanchi R, Rabkin C, Willis J, Wang K, McCall S, Mishra L, Ojesina A, Bullman S, Pedamallu C, Lazar A, Sakai R, Thorsson V, Bass A, Laird P. (2018) Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. Cancer Cell 4:721-735.e8.
  35. Luo J, Attard G, Balk S, Bevan C, Burnstein K, Cato L, Cherkasov A, De Bono J, Dong Y, Gao A, Gleave M, Heemers H, Kanayama M, Kittler R, Lang J, Lee R, Logothetis C, Matusik R, Plymate S, Sawyers C, Selth L, Soule H, Tilley W, Weigel N, Zoubeidi A, Dehm S, Raj G. (2018) Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting. Eur. Urol. 5:715-723. PMC ID: PMC5929166
  36. Luo Y, Kim E, Flask C, Clark H. (2018) Nanosensors for the Chemical Imaging of Acetylcholine Using Magnetic Resonance Imaging. ACS Nano :.
  37. Mack S, Pajtler K, Chavez L, Okonechnikov K, Bertrand K, Wang X, Erkek S, Federation A, Song A, Lee C, Wang X, McDonald L, Morrow J, Saiakhova A, Sin-Chan P, Wu Q, Michaelraj K, Miller T, Hubert C, Ryzhova M, Garzia L, Donovan L, Dombrowski S, Factor D, Luu B, Valentim C, Gimple R, Morton A, Kim L, Prager B, Lee J, Wu X, Zuccaro J, Thompson Y, Holgado B, Reimand J, Ke S, Tropper A, Lai S, Vijayarajah S...Scacheri P... (2018) Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling. Nature 7686:101-105.
  38. Man J, Yu X, Huang H, Zhou W, Xiang C, Huang H, Miele L, Liu Z, Bebek G, Bao S, Yu J. (2018) Hypoxic Induction of Vasorin Regulates Notch1 Turnover to Maintain Glioma Stem-like Cells. Cell Stem Cell 1:104-118.e6. PMC ID: PMC5756127
  39. Mangadlao J, Wang X, McCleese C, Escamilla M, Ramamurthy G, Wang Z, Govande M, Basilion J, Burda C. (2018) Prostate-Specific Membrane Antigen Targeted Gold Nanoparticles for Theranostics of Prostate Cancer. ACS Nano 4:3714-3725.
  40. McDermott D, Huseni M, Atkins M, Motzer R, Rini B, Escudier B, Fong L, Joseph R, Pal S, Reeves J, Sznol M, Hainsworth J, Rathmell W, Stadler W, Hutson T, Gore M, Ravaud A, Bracarda S, Suárez C, Danielli R, Gruenwald V, Choueiri T, Nickles D, Jhunjhunwala S, Piault-Louis E, Thobhani A, Qiu J, Chen D, Hegde P, Schiff C, Fine G, Powles T. (2018) Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma. Nat. Med. :.
  41. Mo F, Lin D, Takhar M, Ramnarine V, Dong X, Bell R, Volik S, Wang K, Xue H, Wang Y, Haegert A, Anderson S, Brahmbhatt S, Erho N, Wang X, Gout P, Morris J, Karnes R, Den R, Klein E, Schaeffer E, Ross A, Ren S, Sahinalp S, Li Y, Xu X, Wang J, Wang J, Gleave M, Davicioni E, Sun Y, Wang Y, Collins C. (2018) Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer. Eur. Urol. 4:524-532.
  42. Moinova H, LaFramboise T, Lutterbaugh J, Chandar A, Dumot J, Faulx A, Brock W, De la Cruz Cabrera O, Guda K, Barnholtz-Sloan J, Iyer P, Canto M, Wang J, Shaheen N, Thota P, Willis J, Chak A, Markowitz S. (2018) Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett's esophagus. Sci Transl Med 424:. PMC ID: PMC5789768
  43. Molenaar R, Pleyer C, Radivoyevitch T, Sidana S, Godley A, Advani A, Gerds A, Carraway H, Kalaycio M, Nazha A, Adelstein D, Nasr C, Angelini D, Maciejewski J, Majhail N, Sekeres M, Mukherjee S. (2018) Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodine. Leukemia 4:952-959.
  44. Morgans A, Chen Y, Sweeney C, Jarrard D, Plimack E, Gartrell B, Carducci M, Hussain M, Garcia J, Cella D, DiPaola R, Patrick-Miller L. (2018) Quality of Life During Treatment With Chemohormonal Therapy: Analysis of E3805 Chemohormonal Androgen Ablation Randomized Trial in Prostate Cancer. J. Clin. Oncol. 11:1088-1095. PMC ID: PMC5891128
  45. Morrow J, Bayles I, Funnell A, Miller T, Saiakhova A, Lizardo M, Bartels C, Kapteijn M, Hung S, Mendoza A, Dhillon G, Chee D, Myers J, Allen F, Gambarotti M, Righi A, DiFeo A, Rubin B, Huang A, Meltzer P, Helman L, Picci P, Versteeg H, Stamatoyannopolus J, Khanna C, Scacheri P. (2018) Positively selected enhancer elements endow osteosarcoma cells with metastatic competence. Nat. Med. 2:176-185. PMC ID: PMC5803371
  46. Motzer R, Tannir N, McDermott D, Arén Frontera O, Melichar B, Choueiri T, Plimack E, Barthélémy P, Porta C, George S, Powles T, Donskov F, Neiman V, Kollmannsberger C, Salman P, Gurney H, Hawkins R, Ravaud A, Grimm M, Bracarda S, Barrios C, Tomita Y, Castellano D, Rini B, Chen A, Mekan S, McHenry M, Wind-Rotolo M, Doan J, Sharma P, Hammers H, Escudier B. (2018) Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma. N. Engl. J. Med. 14:1277-1290.
  47. Oran B, Saliba R, Carmazzi Y, de Lima M, Rondon G, Ahmed S, Alousi A, Andersson B, Anderlini P, Alvarez M, Bashir Q, Ciurea S, Fernandez-Vina M, Hosing C, Kebriaei P, Korbling M, Cano P, Khouri I, Marin D, Nieto Y, Olson A, Popat U, Rezvani K, Qazilbash M, Shpall E, Champlin R, Cao K. (2018) Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion. Blood 11:1248-1257.
  48. Padron E, Ball M, Teer J, Painter J, Yoder S, Zhang C, Zhang L, Moscinski L, Rollison D, Gore S, Bejar R, Walter M, Sekeres M, Komrokji R, Epling-Burnette P. (2018) Germline Tissues for Optimal Somatic Variant Detection in Myelodysplastic Syndromes (MDS). Blood :.
  49. Puchalski R, Shah N, Miller J, Dalley R, Nomura S, Yoon J, Smith K, Lankerovich M, Bertagnolli D, Bickley K, Boe A, Brouner K, Butler S, Caldejon S, Chapin M, Datta S, Dee N, Desta T, Dolbeare T, Dotson N, Ebbert A, Feng D, Feng X, Fisher M, Gee G, Goldy J, Gourley L, Gregor B, Gu G, Hejazinia N, Hohmann J, Hothi P, Howard R, Joines K, Kriedberg A, Kuan L, Lau C, Lee F, Lee H, Lemon T...Barnholtz-Sloan JS...Lathia JD... (2018) An anatomic transcriptional atlas of human glioblastoma. Science 6389:660-663.
  50. Rishavy M, Hallgren K, Wilson L, Singh S, Runge K, Berkner K. (2018) Warfarin alters vitamin K metabolism: a surprising mechanism of VKORC1 uncoupling necessitates an additional reductase. Blood :.
  51. Sakai H, Hosono N, Nakazawa H, Przychodzen B, Polprasert C, Carraway H, Sekeres M, Radivoyevitch T, Yoshida K, Sanada M, Yoshizato T, Kataoka K, Nakagawa M, Ueno H, Nannya Y, Kon A, Shiozawa Y, Takeda J, Shiraishi Y, Chiba K, Miyano S, Singh J, Padgett R, Ogawa S, Maciejewski J, Makishima H. (2018) A novel genetic and morphologic phenotype of ARID2-mediated myelodysplasia. Leukemia 3:839-843.
  52. Shi Y, Guryanova O, Zhou W, Liu C, Huang Z, Fang X, Wang X, Chen C, Wu Q, He Z, Wang W, Zhang W, Jiang T, Liu Q, Chen Y, Wang W, Wu J, Kim L, Gimple R, Feng H, Kung H, Yu J, Rich J, Ping Y, Bian X, Bao S. (2018) Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance. Sci Transl Med 443:.
  53. Siegel S, Stock W, Johnson R, Advani A, Muffly L, Douer D, Reed D, Lewis M, Freyer D, Shah B, Luger S, Hayes-Lattin B, Jaboin J, Coccia P, DeAngelo D, Seibel N, Bleyer A. (2018) Pediatric-Inspired Treatment Regimens for Adolescents and Young Adults With Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Review. JAMA Oncol :.
  54. Spratt D, Zhang J, Santiago-Jiménez M, Dess R, Davis J, Den R, Dicker A, Kane C, Pollack A, Stoyanova R, Abdollah F, Ross A, Cole A, Uchio E, Randall J, Nguyen H, Zhao S, Mehra R, Glass A, Lam L, Chelliserry J, du Plessis M, Choeurng V, Aranes M, Kolisnik T, Margrave J, Alter J, Jordan J, Buerki C, Yousefi K, Haddad Z, Davicioni E, Trabulsi E, Loeb S, Tewari A, Carroll P, Weinmann S, Schaeffer E, Klein E, Karnes R. (2018) Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer. J. Clin. Oncol. 6:581-590.
  55. Statler A, Othus M, Erba H, Chauncey T, Radich J, Coutre S, Advani A, Nand S, Ravandi F, Mukherjee S, Sekeres M. (2018) Comparable Outcomes of Patients Eligible versus Ineligible for SWOG Leukemia Studies. Blood :.
  56. Stein E, Walter R, Erba H, Fathi A, Advani A, Lancet J, Ravandi F, Kovacsovics T, DeAngelo D, Bixby D, Faderl S, Jillella A, Ho P, O'Meara M, Zhao B, Biddle-Snead C, Stein A. (2018) A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemia. Blood 4:387-396. PMC ID: PMC5813721
  57. Sun W, Malvar J, Sposto R, Verma A, Wilkes J, Dennis R, Heym K, Laetsch T, Widener M, Rheingold S, Oesterheld J, Hijiya N, Sulis M, Huynh V, Place A, Bittencourt H, Hutchinson R, Messinger Y, Chang B, Matloub Y, Ziegler D, Gardner R, Cooper T, Ceppi F, Hermiston M, Dalla-Pozza L, Schultz K, Gaynon P, Wayne A, Whitlock J. (2018) Outcome of children with multiply relapsed B-cell acute lymphoblastic leukemia: a therapeutic advances in childhood leukemia & lymphoma study. Leukemia :.
  58. Thiagarajan P, Sinyuk M, Turaga S, Mulkearns-Hubert E, Hale J, Rao V, Demelash A, Saygin C, China A, Alban T, Hitomi M, Torre-Healy L, Alvarado A, Jarrar A, Wiechert A, Adorno-Cruz V, Fox P, Calhoun B, Guan J, Liu H, Reizes O, Lathia J. (2018) Cx26 drives self-renewal in triple-negative breast cancer via interaction with NANOG and focal adhesion kinase. Nat Commun 1:578. PMC ID: PMC5805730
  59. Wang X, Prager B, Wu Q, Kim L, Gimple R, Shi Y, Yang K, Morton A, Zhou W, Zhu Z, Obara E, Miller T, Song A, Lai S, Hubert C, Jin X, Huang Z, Fang X, Dixit D, Tao W, Zhai K, Chen C, Dong Z, Zhang G, Dombrowski S, Hamerlik P, Mack S, Bao S, Rich J. (2018) Reciprocal Signaling between Glioblastoma Stem Cells and Differentiated Tumor Cells Promotes Malignant Progression. Cell Stem Cell 4:514-528.e5. PMC ID: PMC5947947
  60. Wolf D, Anto-Michel N, Blankenbach H, Wiedemann A, Buscher K, Hohmann J, Lim B, Bäuml M, Marki A, Mauler M, Duerschmied D, Fan Z, Winkels H, Sidler D, Diehl P, Zajonc D, Hilgendorf I, Stachon P, Marchini T, Willecke F, Schell M, Sommer B, von Zur Muhlen C, Reinöhl J, Gerhardt T, Plow E, Yakubenko V, Libby P, Bode C, Ley K, Peter K, Zirlik A. (2018) A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense. Nat Commun 1:525. PMC ID: PMC5802769
  61. Wrangle J, Velcheti V, Patel M, Garrett-Mayer E, Hill E, Ravenel J, Miller J, Farhad M, Anderton K, Lindsey K, Taffaro-Neskey M, Sherman C, Suriano S, Swiderska-Syn M, Sion A, Harris J, Edwards A, Rytlewski J, Sanders C, Yusko E, Robinson M, Krieg C, Redmond W, Egan J, Rhode P, Jeng E, Rock A, Wong H, Rubinstein M. (2018) ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial. Lancet Oncol. 5:694-704.
  62. Yakubenko V, Cui K, Ardell C, Brown K, West X, Gao D, Stefl S, Salomon R, Podrez E, Byzova T. (2018) Oxidative modifications of extracellular matrix promote the second wave of inflammation via ß Blood :.
  63. Yan J, Chen S, Local A, Liu T, Qiu Y, Dorighi K, Preissl S, Rivera C, Wang C, Ye Z, Ge K, Hu M, Wysocka J, Ren B. (2018) Histone H3 lysine 4 monomethylation modulates long-range chromatin interactions at enhancers. Cell Res. 2:204-220. PMC ID: PMC5799818
  64. Yan J, Chen S, Local A, Liu T, Qiu Y, Dorighi K, Preissl S, Rivera C, Wang C, Ye Z, Ge K, Hu M, Wysocka J, Ren B. (2018) Histone H3 lysine 4 monomethylation modulates long-range chromatin interactions at enhancers. Cell Res. 3:387. PMC ID: PMC5835777
  65. Zhang Y, An L, Xu J, Zhang B, Zheng W, Hu M, Tang J, Yue F. (2018) Enhancing Hi-C data resolution with deep convolutional neural network HiCPlus. Nat Commun 1:750. PMC ID: PMC5821732
  66. Zhang Y, Pitchiaya S, Cieślik M, Niknafs Y, Tien J, Hosono Y, Iyer M, Yazdani S, Subramaniam S, Shukla S, Jiang X, Wang L, Liu T, Uhl M, Gawronski A, Qiao Y, Xiao L, Dhanasekaran S, Juckette K, Kunju L, Cao X, Patel U, Batish M, Shukla G, Paulsen M, Ljungman M, Jiang H, Mehra R, Backofen R, Sahinalp C, Freier S, Watt A, Guo S, Wei J, Feng F, Malik R, Chinnaiyan A. (2018) Analysis of the androgen receptor-regulated lncRNA landscape identifies a role for ARLNC1 in prostate cancer progression. Nat. Genet. 6:814-824. PMC ID: PMC5980762